Hansa
HNSA.STHansa Biopharma AB (publ) Price (HNSA.ST)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
62,834,848
(19.5941)%Revenue and Profitability
| Year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 103,675 | 2,983,759 | 4,448,186 | 1,282,219 | 2,618,835 | 1,727,017 | 4,716,000 | 5,434,000 | 2,579,000 | 3,442,000 | 3,358,000 | 3,364,000 | 6,098,000 | 33,878,000 | 154,525,000 | 134,094,000 | 171,316,000 |
| Net Income | -2,558,185 | -15,812,150 | -18,843,239 | -24,572,021 | -16,466,035 | -17,561,999 | -29,042,000 | -66,266,000 | -111,129,000 | -176,660,000 | -247,974,000 | -360,009,000 | -420,853,000 | -548,282,000 | -611,134,000 | -831,720,000 | -806,739,000 |
| FCF USD | -19,510,934 | -13,804,949 | -18,093,957 | -27,139,111 | -23,339,567 | -14,929,778 | -24,827,000 | -59,116,000 | -95,547,000 | -152,514,000 | -207,053,000 | -338,203,000 | -290,568,000 | -483,567,000 | -506,064,000 | -755,938,000 | -734,038,000 |
| OCF USD | -15,576,021 | -13,792,299 | -18,093,957 | -27,139,111 | -20,633,032 | -14,865,322 | -23,623,000 | -57,799,000 | -94,563,000 | -150,105,000 | -204,560,000 | -334,775,000 | -290,274,000 | -481,168,000 | -502,733,000 | -755,654,000 | -733,922,000 |
Financial Health - DEBT
| Year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | -0.51 | - | - | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.05 | -1.28 | -1.03 | -1.33 |
| D/E | 0.00 | 0.32 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.05 | 1.31 | -5.16 | -1.83 |
| CA/CL | 1.86 | 0.34 | 0.25 | 0.47 | 8.36 | 0.38 | 2.71 | 14.25 | 9.99 | 14.32 | 11.98 | 6.51 | 12.20 | 5.50 | 6.06 | 2.66 | 2.29 |
| TA/TL | 10.86 | 2.88 | 6.71 | 6.61 | 25.74 | 9.96 | 12.05 | 17.84 | 11.52 | 13.68 | 11.12 | 6.55 | 7.46 | 3.97 | 1.56 | 0.86 | 0.58 |
| Total Debt | 0 | 8,000,000 | 0 | 0 | 0 | 518,724 | 130,000 | 91,000 | 48,000 | 403,000 | 577,000 | 9,459,000 | 5,045,000 | 35,379,000 | 791,092,000 | 866,768,000 | 1,079,007,000 |
Management Performance
| Year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 161.98% | -47.81% | -58.14% | 70.49% | -27.12% | -38.35% | -49.55% | -31.28% | -39.00% | -27.63% | -29.31% | -62.34% | -32.51% | -65.54% | -41.56% | -112.04% | -115.11% |
| ROE | -6.28% | -63.45% | -58.58% | -70.80% | -26.04% | -38.45% | -58.31% | -31.33% | -39.17% | -28.01% | -28.84% | -63.97% | -33.88% | -72.37% | -101.36% | 495.44% | 136.89% |
| ROA | 0.00% | -41.26% | 0.00% | 0.00% | -25.54% | -34.74% | -45.50% | -29.54% | -35.77% | -25.88% | -26.09% | -54.15% | -29.47% | -54.13% | -36.22% | -81.70% | -100.76% |
| NM % | -2,467.50% | -529.94% | -423.62% | -1,916.37% | -628.75% | -1,016.90% | -615.82% | -1,219.47% | -4,309.00% | -5,132.48% | -7,384.57% | -10,701.81% | -6,901.49% | -1,618.40% | -395.49% | -620.25% | -470.91% |
| FCF / R% | 0.00% | -462.67% | -406.77% | -2,116.57% | -891.22% | -864.48% | -526.44% | -1,087.89% | -3,704.81% | -4,430.97% | -6,165.96% | -10,053.60% | -4,764.97% | -1,427.38% | -327.50% | -563.74% | -428.47% |
| FCF / NI% | 122.67% | 87.70% | - | - | 138.86% | 84.64% | 100.48% | 89.30% | 85.97% | 86.61% | 84.00% | 94.03% | 68.72% | 88.20% | 82.81% | 90.89% | 90.99% |
| Operating Margin (OM) | 0.00 | -3.11 | 0.00 | 0.00 | -6.29 | -10.17 | -2.01 | -13.94 | -72.45 | -105.61 | -182.10 | -288.89 | -215.10 | -54.90 | -15.99 | -24.63 | 0.00 |
Per Share
| Year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | -0.51 | -3.12 | -2.27 | -2.11 | -0.71 | -0.72 | -1.09 | -2.12 | -3.37 | -4.97 | -6.47 | -9.00 | -9.98 | -12.33 | -13.60 | -15.83 | -12.84 |
| SPS | 0.02 | 0.59 | 0.54 | 0.11 | 0.11 | 0.07 | 0.18 | 0.17 | 0.08 | 0.10 | 0.09 | 0.08 | 0.14 | 0.76 | 3.44 | 2.55 | 2.73 |
| OCPS | -3.11 | -2.72 | -2.18 | -2.33 | -0.89 | -0.61 | -0.89 | -1.85 | -2.87 | -4.23 | -5.34 | -8.37 | -6.88 | -10.82 | -11.19 | -14.38 | -11.68 |
| FCPS | -3.90 | -2.73 | -2.18 | -2.33 | -1.00 | -0.61 | -0.94 | -1.89 | -2.90 | -4.29 | -5.40 | -8.45 | -6.89 | -10.87 | -11.26 | -14.39 | -11.68 |
| BVPS | 8.14 | 4.92 | 3.87 | 2.98 | 2.72 | 1.86 | 1.88 | 6.78 | 8.60 | 17.76 | 22.44 | 14.06 | 29.45 | 17.03 | 13.42 | -3.20 | -9.38 |
Per Share - CAGR
| Year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.51 | -3.12 | -2.27 | -2.11 | -0.71 | -0.72 | -1.09 | -2.12 | -3.37 | -4.97 | -6.47 | -9.00 | -9.98 | -12.33 | -13.60 | -15.83 | -12.84 |
| CAGR-SPS | 0.02 | 0.59 | 0.54 | 0.11 | 0.11 | 0.07 | 0.18 | 0.17 | 0.08 | 0.10 | 0.09 | 0.08 | 0.14 | 0.76 | 3.44 | 2.55 | 2.73 |
| CAGR-OCPS | -3.11 | -2.72 | -2.18 | -2.33 | -0.89 | -0.61 | -0.89 | -1.85 | -2.87 | -4.23 | -5.34 | -8.37 | -6.88 | -10.82 | -11.19 | -14.38 | -11.68 |
| CAGR-FCPS | -3.90 | -2.73 | -2.18 | -2.33 | -1.00 | -0.61 | -0.94 | -1.89 | -2.90 | -4.29 | -5.40 | -8.45 | -6.89 | -10.87 | -11.26 | -14.39 | -11.68 |
| CAGR-BVPS | 8.14 | 4.92 | 3.87 | 2.98 | 2.72 | 1.86 | 1.88 | 6.78 | 8.60 | 17.76 | 22.44 | 14.06 | 29.45 | 17.03 | 13.42 | -3.20 | -9.38 |